Gamco Investors INC. ET AL Grows Stock Holdings in Olink Holding AB (publ) (NASDAQ:OLK)

Gamco Investors INC. ET AL increased its stake in shares of Olink Holding AB (publ) (NASDAQ:OLK) by 7.1% in the 1st quarter, Holdings Channel reports. The firm owned 179,400 shares of the company’s stock after buying an additional 11,900 shares during the period. Gamco Investors INC. ET AL’s holdings in Olink Holding AB (publ) were worth $4,218,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently made changes to their positions in OLK. Assetmark Inc. raised its holdings in shares of Olink Holding AB (publ) by 30.5% during the fourth quarter. Assetmark Inc. now owns 2,874 shares of the company’s stock valued at $72,000 after purchasing an additional 672 shares during the last quarter. PenderFund Capital Management Ltd. purchased a new stake in Olink Holding AB (publ) during the fourth quarter valued at approximately $393,000. Ardent Capital Management Inc. purchased a new stake in Olink Holding AB (publ) during the first quarter valued at approximately $470,000. Wolverine Asset Management LLC purchased a new stake in Olink Holding AB (publ) during the fourth quarter valued at approximately $692,000. Finally, Virtu Financial LLC purchased a new stake in Olink Holding AB (publ) during the fourth quarter valued at approximately $1,061,000. 30.19% of the stock is owned by hedge funds and other institutional investors.

Olink Holding AB (publ) Stock Performance

OLK stock remained flat at $26.08 during midday trading on Friday. 2,206 shares of the company’s stock were exchanged, compared to its average volume of 633,228. Olink Holding AB has a twelve month low of $14.10 and a twelve month high of $26.09. The company has a market cap of $3.24 billion, a PE ratio of -96.59 and a beta of 0.52. The stock’s 50-day moving average is $25.20 and its 200-day moving average is $24.22.

Olink Holding AB (publ) (NASDAQ:OLK) last announced its earnings results on Monday, May 13th. The company reported ($0.13) EPS for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.01). Olink Holding AB (publ) had a negative net margin of 19.72% and a negative return on equity of 7.07%. The business had revenue of $28.75 million for the quarter, compared to analysts’ expectations of $31.29 million. Sell-side analysts anticipate that Olink Holding AB will post -0.19 earnings per share for the current fiscal year.

About Olink Holding AB (publ)

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on.